'Senolytic' Therapy Shows Promise in Neovascular Eye Disease

(MedPage Today) -- NEW YORK CITY -- An investigational drug targeting senescent cells achieved sustained improvement in visual acuity in patients with diabetic macular edema (DME) or neovascular age-related macular degeneration (AMD), a small...
Source: MedPage Today Endocrinology - Category: Endocrinology Source Type: news